Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Graham Curren, Founder & CEO of Sondrel, expresses confidence in the company's IPO prospects despite market conditions.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Graham Curren, Founder & CEO of Sondrel
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
A data-driven solution designed to power the future of how brands grow|Alex Song,Co-Founder and Chairman,Innovation Department
00:10:00
Put substantial capital and strategic resources into each company throughout its lifecycle|Peter Wagner,Founding Partner,Wing Venture Capital
00:00:00
Adam Hill, CEO, Oncimmune Holdings
00:10:00
Pioneering Black Business and Breaking Barriers | Robert L. Johnson, Chairman , RLJ Companies .
00:10:00
Special Needs Planning: Managing Emotions for Effective Planning | Emily Wood, Partner and Chief Client Officer at Connecticut Wealth Management
00:10:00
Phil Wild, Managing Director expressing about AURES Insight | Patrick Cathala, Founder, Chairman & CEO, Aures Technologies SAAURS:PAR
00:10:00
Science Is Their Superpower: Dr. Hyun Jung Cho | Hyun-Jung Cho, CEO, BITComputer3285K:KOE
00:10:00
Assima and IBM at London, UK's Learning Technologies 2020 | Brendan Scullion, COO, Assima PLCALSIM:PAR
00:10:00
Autonomous software is being developed by Aurora Labs | Zohar Fox, Co-founder & CEO, Aurora Labs Ltd A3D:ASX
00:10:00
Unveiling Dimensional: From Basketball Courts to Investment Portfolios | Dave Butler, CEO , Dimensional Fund Advisors.
00:10:00
Mariano Gomide de Faria, Founder and Co-CEO of VTEX, joins NYSE Floor Talk for a discussion.|Gomide de Faria is our Founder and Co-Chief Executive Officer,
00:10:00
New Labour Government: Navigating Fiscal Challenges and Investment Implications | Oliver Jones - Head of Asset Allocation at Rathbones Group Plc